Abstract
Designing nanomaterials for bio-imaging and drug delivery for advanced cancer therapy with biodegradability and biocompatibility is a promising but challenging frontier. Herein, we assembled biodegradable and biocompatible ultrathin rare-earth erbium/dysprosium nanosheets that improve contrast in multimodal bio-imaging settings (MRI and X-ray CT) and deliver CRISPR-Cas9 plasmid to treat tumors. © The Royal Society of Chemistry 2021.
| Original language | English |
|---|---|
| Pages (from-to) | 9386-9389 |
| Journal | Chemical Communications |
| Volume | 57 |
| Issue number | 74 |
| Online published | 10 Aug 2021 |
| DOIs | |
| Publication status | Published - 21 Sept 2021 |
| Externally published | Yes |
Funding
We thank the National Key R&D Program of China (2018YFA0902600, 2017YFA0205901), the NSFC of China (21535001, 81730051, 21761142006) and the Chinese Academy of Science (QYZDJ-SSW-SLH039, 121D11KYSB20170026, XDA16020902), Tencent Foundation through the XPLORER PRIZE for the financial support. Shenzhen Key Laboratory of Smart Healthcare Engineering (ZDSYS20200811144003009).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Biodegradable freestanding rare-earth nanosheets promote multimodal imaging and delivers CRISPR-Cas9 plasmid against tumor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver